(Alliance News) - Stocks in London were higher at the close on Wednesday as investor waited with bated breath for the US Federal Reserve's next interest rate decision. Read More
(Alliance News) - Pfizer Inc will begin offloading its 32% stake in Haleon PLC as it focuses on reducing debt linked to its USD43 billion acquisition of Seagen Inc and boosting returns to shareholders, according to the Financial Times. Read More
(Alliance News) - Stock prices in London opened in the green on Wednesday, as investors await what is anticipated to be the final interest rate hike from the US Federal Reserve this tightening cycle. Read More
(Alliance News) - Derren Nathan, head of equity research at Hargreaves Lansdown, said that GSK PLC got off to a "healthy start" to 2023, despite the pharmaceutical firm reporting a slip in first quarter sales. Read More
(Alliance News) - London's FTSE 100 closed flat on Thursday, paring earlier losses and outperforming European peers, which were dragged lower by share price slumps for automotive firms. Read More
(Alliance News) - Stocks in Europe were lower heading into Thursday afternoon, with stock markets unable to shake off interest rate worries, while the mining sector kept the FTSE 100 in check once again. Read More
(Alliance News) - Haleon PLC's range of name-brand consumer products seem to be performing well in 2023 so far, despite elevated inflation making consumers increasingly cost-conscious. Read More
(Alliance News) - Stock prices in London edged into the red, following tepid trade in the US and Asia, while oil prices continued to fall on a weak global demand outlook, dragging down oil company shares. Read More
(Alliance News) - Stocks in London closed largely lower on Wednesday, while the FTSE 100 ended in the green thanks to a solid performance from utility and pharmaceutical stocks. Read More
(Alliance News) - Stocks in London finished lower on Tuesday, while the pound reached its highest level since June, as concerns around last month's banking crisis re-emerged. Read More
(Alliance News) - Pharmaceutical company GSK PLC on Friday said it disagrees with a California state court ruling on Zantac and its links with cancer. Read More